SOSV

DXwand, LLC specializes in developing an AI-driven cognitive CRM software aimed at enhancing customer relationship management through automated responses across social channels. Founded in 2018 and based in Cheyenne, Wyoming, the company offers a platform that enables businesses to create, host, and manage intelligent chatbots. These chatbots engage customers in real time via various applications, including social media and messaging platforms, providing 24/7 support. By converting customer interactions into actionable insights and analytics, DXwand assists enterprises in making data-driven decisions that support growth. Additionally, the platform facilitates sales processes by allowing companies to sell products, track orders, and generate leads directly from customer conversations, thereby optimizing the customer experience and accelerating revenue generation.

Solving gout using engineered probiotics

DXwand, LLC specializes in developing an AI-driven cognitive CRM software aimed at enhancing customer relationship management through automated responses across social channels. Founded in 2018 and based in Cheyenne, Wyoming, the company offers a platform that enables businesses to create, host, and manage intelligent chatbots. These chatbots engage customers in real time via various applications, including social media and messaging platforms, providing 24/7 support. By converting customer interactions into actionable insights and analytics, DXwand assists enterprises in making data-driven decisions that support growth. Additionally, the platform facilitates sales processes by allowing companies to sell products, track orders, and generate leads directly from customer conversations, thereby optimizing the customer experience and accelerating revenue generation.

AsimicA focuses on developing novel technologies for improved production in Microbial Biosynthetic Factories. Their technologies have the potential for a multi-fold increase in yields of biosynthetic processes. Since relatively low yields of target products, made through the biosynthesis is the major limitation of biotechnology, our innovative approaches for production may revolutionize the industry. AsimicA was launched in November 2018, by Nikolai Mushnikov and Grant Bowman.

Rocketship.vc is an early-stage venture capital firm based in Los Altos, California, founded in 2013. The firm specializes in investing in life science and technology companies across various sectors, including artificial intelligence, cloud storage, e-commerce, education, financial software, logistics, and real estate. Utilizing a proprietary algorithm known as Escape Velocity, Rocketship.vc identifies companies with a Sustainable Growth Engine, focusing on those that leverage data science in their business models. The firm operates as a Registered Investment Adviser and aims to support innovative enterprises that demonstrate strong growth potential.

AsimicA focuses on developing novel technologies for improved production in Microbial Biosynthetic Factories. Their technologies have the potential for a multi-fold increase in yields of biosynthetic processes. Since relatively low yields of target products, made through the biosynthesis is the major limitation of biotechnology, our innovative approaches for production may revolutionize the industry. AsimicA was launched in November 2018, by Nikolai Mushnikov and Grant Bowman.

AsimicA focuses on developing novel technologies for improved production in Microbial Biosynthetic Factories. Their technologies have the potential for a multi-fold increase in yields of biosynthetic processes. Since relatively low yields of target products, made through the biosynthesis is the major limitation of biotechnology, our innovative approaches for production may revolutionize the industry. AsimicA was launched in November 2018, by Nikolai Mushnikov and Grant Bowman.